ARTICLE | Clinical News
SciFluor preclinical data
July 29, 2013 7:00 AM UTC
In a mouse model of epilepsy, SF0034 led to a 5-fold increase in potency with reduced corrected QT (QTc) liabilities and a more balanced excretion prole compared to Potiga ezogabine. Data were presen...